Literature DB >> 12669121

Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases.

Thomas Kietzmann1, Kurt Jungermann, Agnes Görlach.   

Abstract

Mitogen-activated protein kinases (MAPKs) and protein kinase B (PKB) mediate growth and stress signals and have been implicated in the hypoxic response. Under hypoxic conditions, the expression of plasminogen activator inhibitor-1 (PAI-1) is mainly controlled by the hypoxia-inducible factor HIF-1. However, the role of MAPKs and PKB in HIF-1-mediated PAI-1 regulation is not clear. Treatment with the p38 inhibitor SB203580 and the PI3K inhibitor LY294002, but not with the MEK1 inhibitor PD98059, abrogated hypoxia-dependent PAI-1 induction in HepG2 cells. Consistently, overexpression of PKB or of the p38 upstream kinases MKK6 and MKK3 and of JNK, but not of ERK, enhanced PAI-1 mRNA levels. In MKK3-, MKK6- and PKB-expressing cells luciferase (Luc) activities from a hypoxia-inducible PAI-1-Luc construct or from a HIF-dependent Luc construct and, concomitantly, HIF-1alpha protein levels were enhanced. These findings indicate that p38- and PKB-dependent signalling pathways contribute to enhanced PAI-1 levels in the hypoxic response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669121

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

Review 1.  Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines.

Authors:  Savalan Babapoor-Farrokhran; Deanna Gill; Jafar Alzubi; Sumeet K Mainigi
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

2.  Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.

Authors:  Daniela Flügel; Agnes Görlach; Carine Michiels; Thomas Kietzmann
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

3.  Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.

Authors:  Brandi R Whitley; Lea M Beaulieu; Jennifer C Carter; Frank C Church
Journal:  Gynecol Oncol       Date:  2006-10-30       Impact factor: 5.482

4.  Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.

Authors:  Maria U Rømer; Lise Larsen; Hanne Offenberg; Nils Brünner; Ulrik A Lademann
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 5.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

6.  Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.

Authors:  Rachida S Belaiba; Steve Bonello; Christian Zähringer; Stefanie Schmidt; John Hess; Thomas Kietzmann; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

7.  HIF-1alpha activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death.

Authors:  L Zhang; L Li; H Liu; K Prabhakaran; X Zhang; J L Borowitz; G E Isom
Journal:  Free Radic Biol Med       Date:  2007-04-10       Impact factor: 7.376

Review 8.  Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Authors:  Agnes Görlach; Elitsa Y Dimova; Andreas Petry; Antonio Martínez-Ruiz; Pablo Hernansanz-Agustín; Anabela P Rolo; Carlos M Palmeira; Thomas Kietzmann
Journal:  Redox Biol       Date:  2015-08-28       Impact factor: 11.799

9.  Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity.

Authors:  Ze Zheng; Keiko Nakamura; Shana Gershbaum; Xiaobo Wang; Sherry Thomas; Marc Bessler; Beth Schrope; Abraham Krikhely; Rui-Ming Liu; Lale Ozcan; José A López; Ira Tabas
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 19.456

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.